...
首页> 外文期刊>American Journal of Physiology >Abnormal EGF-dependent regulation of sodium absorption in ARPKD collecting duct cells.
【24h】

Abnormal EGF-dependent regulation of sodium absorption in ARPKD collecting duct cells.

机译:EPK依赖的ARPKD收集导管细胞中钠吸收的异常调节。

获取原文
获取原文并翻译 | 示例

摘要

Amiloride-sensitive sodium entry, via the epithelial sodium channel (ENaC), is the rate-limiting step for Na+ absorption in kidney collecting ducts, and epidermal growth factor (EGF) inhibits Na+ transport and ENaC expression. A pathognomonic feature of polycystic kidney disease (PKD) is EGF receptor mislocalization to the apical plasma membrane and EGF/EGF receptor axis overactivity. Immunohistochemical and biochemical analysis revealed mislocalization of EGF receptor and excessive activation of the p42/44 extracellular signal-regulated protein kinase pathway (ERK1/2) in kidneys from cystic mice compared with noncystic littermates. Primary monolayer cultures of noncystic and cystic murine collecting duct principal cells were used to identify aberrant EGF-dependent ERK1/2 activation and regulation of Na+ transport associated with autosomal recessive PKD. Addition of EGF to the basolateral bathing solution of noncystic or cystic monolayers led to p42/44 phosphorylation and inhibition of Na+ transport (30-35%), whereas apical EGF was effective only in monolayers derived from cystic mice. p42/44 Phosphorylation and inhibition of Na+ transport were prevented by prior treatment of the cells with an ERK kinase inhibitor. Chronic treatment (24 h) of noncystic and cystic monolayers with basolateral EGF elicited sustained inhibition of Na+ absorption (50-55%) and a reduction in steady-state ENaC mRNA levels (50-75%). In contrast, addition of EGF to the apical bathing solution (24 h) had no effect in noncystic monolayers but led to inhibition of Na+ transport (50-60%) and decreased ENaC expression (45-60%) in cystic cells. Pretreatment of the monolayers with an ERK kinase inhibitor abolished the chronic effects of EGF on Na+ transport. The results of these studies reveal that the mislocalized apical EGF receptors are functionally coupled to the ERK pathway and that abnormal EGF-dependent regulation of ENaC function and expression may contribute to PKD pathophysiology.
机译:通过上皮钠通道(ENaC)对阿米洛利敏感的钠进入是肾脏收集导管中Na +吸收的限速步骤,而表皮生长因子(EGF)抑制Na +转运和ENaC表达。多囊性肾病(PKD)的病理特征是EGF受体在心尖质膜上的定位错误和EGF / EGF受体轴过度活跃。免疫组织化学和生物化学分析显示,与非囊性同窝仔猪相比,囊性小鼠肾脏中EGF受体的定位错误和p42 / 44细胞外信号调节蛋白激酶途径(ERK1 / 2)的过度活化。非囊性和囊性鼠收集管原代细胞的主要单层培养用于鉴定异常EGF依赖的ERK1 / 2激活和与常染色体隐性PKD相关的Na +转运的调节。在非囊性或囊性单层的基底外侧沐浴液中添加EGF会导致p42 / 44磷酸化并抑制Na +转运(30%至35%),而顶端EGF仅在衍生自囊性小鼠的单层中有效。 p42 / 44通过事先用ERK激酶抑制剂处理细胞可防止磷酸化和Na +转运抑制。基底外侧EGF对非囊性和囊性单层的慢性治疗(24 h)引起Na +吸收的持续抑制(50-55%)和稳态ENaC mRNA水平的降低(50-75%)。相比之下,将EGF添加到顶端沐浴液中(24 h)在非囊性单层细胞中没有作用,但是导致Na +转运受到抑制(50-60%),并且在囊性细胞中降低了ENaC表达(45-60%)。用ERK激酶抑制剂预处理单层细胞可以消除EGF对Na +转运的慢性影响。这些研究的结果表明,错位的根尖EGF受体在功能上与ERK通路相关,并且ENaC功能和表达的异常依赖EGF的调节可能有助于PKD病理生理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号